1st Quarter - Amendment
ALLERGAN, INC. for ALLERGAN, INC.
Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 21, 2008 | $410,000 | Replaced |
| 1st Quarter - Amendment | Apr 21, 2008 | $410,000 | Replaced |
| 1st Quarter - Amendment (this page) | Jun 19, 2009 | $400,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Taxation/Internal Revenue Code TAX
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Medicare/Medicaid MMM
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.